AstraZeneca boss: I don't think I would do anything differently:
Pascal Soriot was knighted in the Queen’s Jubilee birthday honours for his contributions to ...
bbc.com/news/business-61671715
Story Details
| Last Updated | |
| Total Articles | 2 |
Main Topics
viral vector vaccine for prevention of COVID-19
News on this topic
Devon Live Jun 07 22
Jab setbacks but AstraZeneca boss 'wouldn't change a thing' : Jab saved one million lives, says Sir Pascal Soriot
walesonline.co.uk/news/uk-news/astrazeneca-boss-wouldnt-change-thing-24160957
Similar to This
Previous
AstraZeneca says its COVID shot still has role despite global glut: AstraZeneca's (AZN.L) COVID-19 vaccine still has a role to play in the fight against the ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-beats-quarterly-estimates-maintains-forecasts-2022-04-29/
AstraZeneca to book modest profit from coronavirus vaccine: British-Swedish pharmaceutical company AstraZeneca says it will start to book a modest profit from ...
abcnews.go.com/Health/wireStory/astrazeneca-book-modest-profit-coronavirus-vaccine-81126754
India warns of reciprocal measures if UK does not address concerns on travel rules related to Covid-19 vaccination
financialexpress.com/lifestyle/travel-tourism/india-warns-of-reciprocal-measures-if-uk-does-not-address-concerns-on-travel-rules-related-to-covid-19-vaccination/2334840/
Covid: Vaccine protection still strong - Oxford jab creator: Prof Dame Sarah Gilbert said offering a booster dose this autumn was "a complex decision".
bbc.com/news/uk-58507436
EU lists rare nerve disorder as possible side-effect of AstraZeneca COVID-19 vaccine
reuters.com/business/healthcare-pharmaceuticals/eu-lists-rare-nerve-disorder-possible-side-effect-astrazeneca-covid-19-vaccine-2021-09-08/
Paid articlePaywall
AstraZeneca chief hits back at ‘armchair generals’ after criticism: Pascal Soriot defends firm and says its booster jab has performed well against new Covid ...
theguardian.com/business/2021/may/22/astrazeneca-chief-hits-back-at-armchair-generals-after-criticism
India says 'minuscule' clotting cases after AstraZeneca vaccine: India has found 26 suspected cases of bleeding and clotting among recipients of the AstraZeneca ...
reuters.com/business/healthcare-pharmaceuticals/india-has-26-potential-cases-bleeding-clotting-after-astrazeneca-vaccine-2021-05-17/
Paid articlePaywall AstraZeneca expected to miss EU Covid vaccine supply target by half in second-quarter – report
theguardian.com/world/2021/feb/24/astrazeneca-expected-to-miss-eu-covid-vaccine-supply-target-by-half-in-second-quarter-report
Exclusive: UK auditing Indian vaccine site amid scramble for shots - sources: Britain's drug regulator is auditing manufacturing processes at Serum Institute of ...
reuters.com/article/health-coronavirus-india-britain-idUSKBN2AF1DB
Coronavirus: AstraZeneca defends EU vaccine rollout plan: The pharmaceutical giant said the late signing of contracts limited time to sort out supply glitches.
bbc.com/news/world-europe-55817633
EU rejects representation of Astrazeneca: According to vaccine manufacturer Astrazeneca, there is no obligation to deliver certain quantities to the EU ...
tagesspiegel.de/politik/streit-mit-impfstoffhersteller-eu-weist-darstellung-von-astrazeneca-zurueck/26857918.html
AstraZeneca's vaccine is expected to work on new COVID-19 strains, says CEO - Business Insider
businessinsider.com/astrazeneca-vaccine-seen-working-for-new-covid-19-strains-2020-12
Oxford Covid vaccine 'safe and effective' study shows: The peer-reviewed work in the Lancet medical journal confirms the vaccine is 'safe and protects' ...
bbc.com/news/health-55228422
AstraZeneca and Oxford Say Vaccine Is Up to 90 Percent Effective: In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.
nytimes.com/2020/11/23/business/astrazeneca-oxford-coronavirus-vaccine.html
Covid: Oxford vaccine shows 'encouraging' immune response in older adults: The phase two trial results raise hopes the jab can protect age groups most at risk ...
bbc.co.uk/news/health-54993652
Covid-19 vaccine in October ?: Biontech wants to test 44,000 subjects: The expectations of the developers of a potential corona vaccine are high ...
n-tv.de/wirtschaft/Biontech-will-44-000-Probanden-testen-article22033775.html
AstraZeneca Covid-19 Vaccine Trials Resume in U.K.: The trials were paused after a subject in the U.K. fell ill, but are restarting after regulators determined ...
wsj.com/articles/astrazeneca-covid-19-vaccine-trials-resume-in-the-u-k-11599922981
Paid articlePaywall Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief: Pharmaceutical giant’s boss says 2020 deadline possible if regulators move fast
theguardian.com/business/2020/sep/10/oxford-covid-19-vaccine-is-still-possible-this-year-says-astrazeneca-chief
The Times and The Sunday Times Sep 09 20
‘Spinal inflammation’ halts Oxford vaccine trial: Trials of Oxford University’s potential Covid vaccine were halted after a British volunteer developed an ...
thetimes.co.uk/article/spinal-inflammation-halts-oxford-vaccine-trial-rc2txfw6g
Paid articlePaywall Next